tryptamines - CISMeF

Preferred Label : tryptamines;

MeSH definition : Decarboxylated monoamine derivatives of TRYPTOPHAN.;

MeSH synonym : indolylethylamines;

Wikipedia automatic translation : Substituted tryptamine;

MeSH hyponym : triptans; Triptan;

Wikipedia link : https://en.wikipedia.org/wiki/Substituted tryptamine;

Is substance : O;

Details

Origin ID

D014363;

UMLS CUI

C0041248;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 2-(indol-3-yl)ethylamine [Substance BNPC]
- Triptans [ICD-11 Extension code]
- Tryptamine [FMA entity]
- Tryptamine [LOINC component]
- Tryptamine (substance) [SNOMED CT concept]
- tryptamines, nos [SNOMED Notion]
Record concept(s)
- triptans [MeSH concept]
- tryptamines [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1H-indol-5-yl)propan-2-amine [MeSH Supplementary Concept]
- (5'-(tryptaminocarbonyl)-2'-deoxyribofuranosyl)thymine [MeSH Supplementary Concept]
- 1-desoxyfructo-alpha,beta-dehydro-4,5-dioxotryptamine [MeSH Supplementary Concept]
- 1-hydroxy-N-methoxycarbonyltryptamine [MeSH Supplementary Concept]
- 11-N-(3-acetylbenzenesulfonyl)undecanoyl tryptamine [MeSH Supplementary Concept]
- 11-N-(3-nitrobenzenesulfonyl)undecanoyl tryptamine [MeSH Supplementary Concept]
- 2,3-dihydro-2-oxotryptamine [MeSH Supplementary Concept]
- 2-(3,5-dimethylphenyl)tryptamine [MeSH Supplementary Concept]
- 2-(N-(2-propynyl)-aminomethyl)-1-methyl-5-hydroxyindole [MeSH Supplementary Concept]
- 2-(N-(2-propynyl)aminomethyl)-1-methyl-5-methoxyindole [MeSH Supplementary Concept]
- 2-(N-(2-propynyl)aminomethyl)-1-methylindole [MeSH Supplementary Concept]
- 2-bromo-N-methyltryptamine [MeSH Supplementary Concept]
- 2-iodo-5-methoxycarbonylamino-N-acetyltryptamine [MeSH Supplementary Concept]
- 4-HO-MET [MeSH Supplementary Concept]
- 4-acetoxy-dimethyltryptamine [MeSH Supplementary Concept]
- 4-fluoro-5-methoxy-N,N-dimethyltryptamine [MeSH Supplementary Concept]
- 5,5'-dihydroxy-4,4'-bitryptamine [MeSH Supplementary Concept]
- 5-(nonyloxy)tryptamine [MeSH Supplementary Concept]
- 5-bromotryptamine [MeSH Supplementary Concept]
- 5-carboxytryptamine [MeSH Supplementary Concept]
- 5-chlorotryptamine [MeSH Supplementary Concept]
- 5-ethyltryptamine [MeSH Supplementary Concept]
- 5-fluoro-alpha-methyltryptamine [MeSH Supplementary Concept]
- 5-fluorotryptamine [MeSH Supplementary Concept]
- 5-methoxy-2-phenyl-N,N-dimethyltryptamine [MeSH Supplementary Concept]
- 5-methoxy-N-methyl,N-isopropyl tryptamine [MeSH Supplementary Concept]
- 5-methoxycarbonylamino-N-acetyltryptamine [MeSH Supplementary Concept]
- 5-methyltryptamine [MeSH Supplementary Concept]
- 5-nonyloxytryptamine [MeSH Supplementary Concept]
- 6-fluoro-N,N-diethyltryptamine [MeSH Supplementary Concept]
- 7-S-glutathionyltryptamine-4,5-dione [MeSH Supplementary Concept]
- 7-azatryptamine [MeSH Supplementary Concept]
- 7-methyltryptamine [MeSH Supplementary Concept]
- BrMT neurotoxin, calliostoma canaliculatum [MeSH Supplementary Concept]
- JNJ 26854165 [MeSH Supplementary Concept]
- L 694247 [MeSH Supplementary Concept]
- LY 293284 [MeSH Supplementary Concept]
- N(1)-(6-chloroimidazo(2,1-b)(1,3)thiazole-5-sulfonyl)tryptamine [MeSH Supplementary Concept]
- N(b)-benzyl-2,3-dihydro-2-oxotryptamine [MeSH Supplementary Concept]
- N, N, N-trimethyl-4-phosphoryloxytryptamine [MeSH Supplementary Concept]
- N,N,N-trimethyltryptamine [MeSH Supplementary Concept]
- N,N-diallyl-5-methoxytryptamine [MeSH Supplementary Concept]
- N,N-diethyltryptamine [MeSH Supplementary Concept]
- N,N-diisopropyltryptamine [MeSH Supplementary Concept]
- N,N-dimethylaminopropyltryptamine [MeSH Supplementary Concept]
- N,N-dipropylcarboxamidotryptamine [MeSH Supplementary Concept]
- N-((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)-5-methoxy-1H-indole-3-ethanamine [MeSH Supplementary Concept]
- N-acetyl-5-ethoxytryptamine [MeSH Supplementary Concept]
- N-acetyltryptamine [MeSH Supplementary Concept]
- N-bromoacetyltryptamine [MeSH Supplementary Concept]
- N-butanoyl-5-methyltryptamine [MeSH Supplementary Concept]
- N-caffeoyltryptamine [MeSH Supplementary Concept]
- N-cyanoethyltryptamine [MeSH Supplementary Concept]
- N-desmethyl eletriptan [MeSH Supplementary Concept]
- N-methyl-5-tert-butyltryptamine [MeSH Supplementary Concept]
- N-methyltryptamine [MeSH Supplementary Concept]
- N-pentanoyl-2-benzyltryptamine [MeSH Supplementary Concept]
- N-salicyloyltryptamine [MeSH Supplementary Concept]
- N1-benzenesulfonyl-5-methoxy-N,N-dimethyltryptamine [MeSH Supplementary Concept]
- NK 122 [MeSH Supplementary Concept]
- SST-VEDI-1 compound [MeSH Supplementary Concept]
- ZTR-5 compound [MeSH Supplementary Concept]
- almotriptan [MeSH Supplementary Concept]
- alpha-methyltryptamine sulfonamide [MeSH Supplementary Concept]
- avitriptan [MeSH Supplementary Concept]
- bacillamide B [MeSH Supplementary Concept]
- bacillamide C [MeSH Supplementary Concept]
- beta-methyltryptamine [MeSH Supplementary Concept]
- bis(6-bromo-2-mercaptotryptamin-2-yl)disulfide [MeSH Supplementary Concept]
- dipropyltryptamine [MeSH Supplementary Concept]
- donitriptan [MeSH Supplementary Concept]
- eletriptan [MeSH Supplementary Concept]
- etryptamine [MeSH Supplementary Concept]
- frovatriptan [MeSH Supplementary Concept]
- granulatamide A [MeSH Supplementary Concept]
- granulatamide B [MeSH Supplementary Concept]
- haploscleridamine [MeSH Supplementary Concept]
- indopan [MeSH Supplementary Concept]
- leptoclinidamide [MeSH Supplementary Concept]
- luzindole [MeSH Supplementary Concept]
- myristoyl tryptamine [MeSH Supplementary Concept]
- naratriptan [MeSH Supplementary Concept]
- rizatriptan [MeSH Supplementary Concept]
- roehybridine-N-oxide [MeSH Supplementary Concept]
- tryptamide [MeSH Supplementary Concept]
- tryptamine [MeSH Supplementary Concept]
- tryptamine-4,5-dione [MeSH Supplementary Concept]
- zolmitriptan [MeSH Supplementary Concept]
See also
- receptors, serotonin [MeSH Descriptor]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Tryptamine [FMA entity]
- Tryptamine (substance) [SNOMED CT concept]
- tryptamines, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients